Abstract
Diffuse senile plaques are characterized by the presence of beta protein (beta P), also called A4 protein, in a dispersed form and the apparent lack of associated dystrophic neurites or reactive glial cells. They are the most common type of senile plaque found in the cerebral cortex in Alzheimer's disease (AD), Down's syndrome (DS), and normal aging. Here is reported the frequent presence of diffuse senile plaques in the molecular layer of cerebellar cortex in AD. Typical neuritic plaques were never detected in this location, making the cerebellar molecular cortex a useful site for the study of diffuse plaques because diffuse plaques in the cerebral cortex are intermingled with neuritic plaques. Diffuse cerebellar plaques were detected by modified Bielschowsky silver stain in 47 of 100 cases of clinically and pathologically diagnosed AD and in none of 40 aged demented and nondemented controls. They were immunolabeled by antibodies to purified AD meningeal or cortical beta P, and to a synthetic beta P but not by two antibodies to the carboxyl- and amino-termini of the beta protein precursor (beta PP), which label a subgroup of cerebral cortical plaques. This latter result suggests that the beta P deposited in the cerebellar molecular layer may be derived from a form of the beta PP from which the carboxyl and amino terminal regions of the precursor have already been cleaved. Diffuse cerebellar plaques were not recognized by antibodies to neurofilaments, tau, and PHF, all of which detect dystrophic neurites in cerebral cortical neuritic plaques. Also, no association of reactive astrocytes or microglial cells with diffuse cerebellar plaques was observed. Thus, diffuse cerebellar plaques represent multifocal deposits of noncompacted beta P that cause little or no morphologic reaction in their microenvironment.
MeSH Terms
Aged
Aged, 80 and over
Alzheimer Disease/metabolism,pathology
Amyloid/immunology,metabolism
Amyloid beta-Peptides
Cerebellum/metabolism,pathology,ultrastructure
Female
Humans
Immunohistochemistry
Male
Microscopy, Electron
Middle Aged
Chemicals
Amyloid
Amyloid beta-Peptides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Joachim C L
Center for Neurologic Diseases, Brigham & Women's Hospital Boston, Massachusetts 02115.
Morris J H
Selkoe D J
References (20)
20 references, click to expand
-
Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.
Brain Res. 1988 Nov 22;474(1):100-11
PMID: 3214703
-
Presenile Alzheimer disease: amyloid plaques in the cerebellum.
Neurology. 1980 Aug;30(8):820-5
PMID: 7191064
-
Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies.
Brain Res. 1984 Sep 24;310(2):249-60
PMID: 6207891
-
Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type.
Ann Neurol. 1985 Mar;17(3):273-7
PMID: 3994315
-
Diagnosis of Alzheimer's disease.
Arch Neurol. 1985 Nov;42(11):1097-105
PMID: 2864910
-
Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8729-32
PMID: 2934737
-
Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.
J Neurochem. 1986 Jun;46(6):1820-34
PMID: 3517233
-
Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.
Science. 1987 Feb 20;235(4791):873-7
PMID: 3544219
-
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.
Science. 1987 Jul 3;237(4810):77-80
PMID: 3299701
-
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.
Lab Invest. 1987 Aug;57(2):230-6
PMID: 2441141
-
Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.
J Neuropathol Exp Neurol. 1987 Nov;46(6):611-22
PMID: 2443617
-
In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1227-31
PMID: 3277188
-
Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Ann Neurol. 1987 Oct;22(4):514-20
PMID: 2963585
-
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Am J Pathol. 1988 Jul;132(1):86-101
PMID: 2456021
-
Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
Ann Neurol. 1988 Jul;24(1):50-6
PMID: 3415200
-
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7341-5
PMID: 3140239
-
Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques.
Biochem Biophys Res Commun. 1988 Oct 14;156(1):432-7
PMID: 3140814
-
A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.
Neurology. 1988 Nov;38(11):1688-93
PMID: 3054625
-
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.
Nature. 1982 Jul 1;298(5869):84-6
PMID: 6178036
-
Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins.
Nature. 1983 Aug 25-31;304(5928):727-30
PMID: 6350889